Answer
Salmeterol xinafoate opens the airways through selective beta-2-adrenoceptor agonist activity, with a long side-chain binding to the receptor’s exo-site, producing bronchodilation lasting at least 12 hours.
Sources for this answer
- Serevent AccuhalerGlaxoSmithKline UK · emc · SmPC §5.1 Pharmacodynamic properties · Version 29Document updated
Sources checked